MedPath

HS-20094

Generic Name
HS-20094

A Study of HS-20094 in Patients With T2DM

Phase 2
Recruiting
Conditions
Type 2 Diabetes
Interventions
First Posted Date
2025-03-30
Last Posted Date
2025-03-30
Lead Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Target Recruit Count
270
Registration Number
NCT06901648
Locations
🇨🇳

Tianjin Medical University General Hospital (Zhu Xianyi Memorial Hospital), Tianjin, Tianjin, China

A Study of HS-20094 Evaluating Weight Loss in Obese and Overweight Chinese Subjects

Phase 2
Recruiting
Conditions
Overweight and Obesity
Interventions
Drug: Placebo
First Posted Date
2023-11-07
Last Posted Date
2023-11-07
Lead Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Target Recruit Count
200
Registration Number
NCT06118021
Locations
🇨🇳

The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China

🇨🇳

the Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China

A Study of HS-20094 in Healthy Participants

Phase 1
Conditions
Type 2 Diabetes
Interventions
Drug: Placebo
First Posted Date
2021-11-11
Last Posted Date
2022-07-19
Lead Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Target Recruit Count
68
Registration Number
NCT05116410
Locations
🇨🇳

Beijing University First Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath